Learn about available technologies from Rutgers Technology Transfer
Rutgers Office for Research proudly presents Rutgers Innovations, the Technology Transfer bulletin that provides updates on Rutgers technologies and highlights collaborative and partnership opportunities for intellectual property-based assets.
Collision-Free Dynamic Window Approach for
Moving Obstacles
Powered wheelchairs can be difficult to navigate in tight spaces, cause fatigue from operations, and can use better collision avoidance technology. Rutgers technology turns a powered wheelchair into an autonomous driving wheelchair. Take a look at this video!
Single-cell Analysis of Host-Microbiome Interactions (SAHMI) identifies differences between human pancreatic ductal adenocarcinomas and control tissue thereby assisting in disease diagnosis and subsequent target for treatment.
A novel amphiphilic macromolecule-based nanotherapeutic technology promotes neuroprotection and lysosomal fibrils clearance thereby offering a potential solution to the multifactorial nature of Alzheimer's disease.
Over 40% of American adults suffer from gum disease. This Rutgers app provides an intuitive interface for healthcare providers to learn how to implement in practice to properly and timely diagnose periodontal patients.
After 20 years of effort, four of Rutgers Hazelnut cultivars that are 'Eastern Filbert Blight' fungus resistant are now available to propagate and grow in the East Coast of the USA.
Rutgers start-up RAPT Ventures Inc.'s patented adaptive training algorithm improves infants' rapid auditory processing skills as well as their ability to generate language skills while they are sleeping. The technology is immensely useful in establishing efficient neurological language maps within children, facilitating language acquisition, reading capabilities, and learning in general.
Derisked through Commercialization Grants
Available technologies that received Rutgers Bridge Funding awards
Orally available, water-soluble, and excellent permeability properties of these small molecule MIF inhibitors can help patients with IBD, arthritis, psoriasis, diabetes, and prostate cancers.
